AI and multiomics identify cancer biomarker and drug target
Source: MasterTux/Pixabay Artificial intelligence (AI) machine learning has the potential to completely revolutionize not only how diseases are detected, but also how to identify personalized treatment based on a patient’s genomics. A new study published in Cell death and diseasepeer review Nature journal, shows how an AI-based multiomics platform can identify novel biomarkers for new …
AI and multiomics identify cancer biomarker and drug target Read More »